The Bombay High Court has directed Abbott Laboratories to halt advertisements that allegedly disparage Hindustan Unilever’s Horlicks Diabetes Plus. The court found a strong prima facie case for HUL, arguing that Abbott's ads negatively portray Horlicks Diabetes Plus. A hearing is scheduled for October 7.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.